These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31455117)

  • 1. Advances in the therapy of BRAF
    Jin Z; Sinicrope FA
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):823-829. PubMed ID: 31455117
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical research progress on BRAF V600E-mutant advanced colorectal cancer.
    Zeng C; Wang M; Xie S; Wang N; Wang Z; Yi D; Kong F; Chen L
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16111-16121. PubMed ID: 37639010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete response of metastatic microsatellite-stable
    Ree AH; Høye E; Esbensen Y; Beitnes AR; Negård A; Bernklev L; Tetlie LK; Fretland ÅA; Hamre HM; Kersten C; Hofsli E; Guren MG; Sorbye H; Nilsen HL; Flatmark K; Meltzer S
    Oncoimmunology; 2024; 13(1):2372886. PubMed ID: 38952672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive overview of the molecular features and therapeutic targets in BRAF
    Gu R; Fang H; Wang R; Dai W; Cai G
    Clin Transl Med; 2024 Jul; 14(7):e1764. PubMed ID: 39073010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer.
    Ozeki H; Shimada Y; Nakano M; Kondo S; Ohashi R; Miwa Y; Yamai D; Matsumoto A; Abe K; Tajima Y; Ichikawa H; Sakata J; Takii Y; Sugai M; Nagai T; Ling Y; Okuda S; Wakai T
    Hum Pathol; 2024 Mar; 145():71-79. PubMed ID: 38423222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention.
    Rad R; Cadiñanos J; Rad L; Varela I; Strong A; Kriegl L; Constantino-Casas F; Eser S; Hieber M; Seidler B; Price S; Fraga MF; Calvanese V; Hoffman G; Ponstingl H; Schneider G; Yusa K; Grove C; Schmid RM; Wang W; Vassiliou G; Kirchner T; McDermott U; Liu P; Saur D; Bradley A
    Cancer Cell; 2013 Jul; 24(1):15-29. PubMed ID: 23845441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors.
    Zou H; Liu C; Ruan Y; Fang L; Wu T; Han S; Dang T; Meng H; Zhang Y
    Expert Rev Clin Immunol; 2024 Aug; 20(8):997-1008. PubMed ID: 38459764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of BRAF
    Liposits G; Winther SB; Ryg J; Skuladottir H; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
    J Geriatr Oncol; 2024 Mar; 15(2):101632. PubMed ID: 37730481
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of
    Takeda H; Sunakawa Y
    Front Oncol; 2021; 11():602194. PubMed ID: 33842313
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Gao C; Esni F; Chu E; Hu J
    Biochem Biophys Rep; 2024 Mar; 37():101634. PubMed ID: 38188365
    [No Abstract]   [Full Text] [Related]  

  • 11. BRAF
    Planchard D; Sanborn RE; Negrao MV; Vaishnavi A; Smit EF
    NPJ Precis Oncol; 2024 Apr; 8(1):90. PubMed ID: 38627602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF
    Piercey O; Tie J; Hollande F; Wong HL; Mariadason J; Desai J
    Clin Colorectal Cancer; 2024 Sep; 23(3):215-229. PubMed ID: 38816264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Testing for Gastrointestinal Cancer.
    Lee HS; Kim WH; Kwak Y; Koh J; Bae JM; Kim KM; Chang MS; Han HS; Kim JM; Kim HW; Chang HK; Choi YH; Park JY; Gu MJ; Lhee MJ; Kim JY; Kim HS; Cho MY; ;
    J Pathol Transl Med; 2017 Mar; 51(2):103-121. PubMed ID: 28219002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer.
    Miyamoto Y; Zhang W; Lenz HJ
    Indian J Surg Oncol; 2017 Dec; 8(4):580-590. PubMed ID: 29203992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors.
    Halama N; Haberkorn U
    Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent insights into nanotechnology development for detection and treatment of colorectal cancer.
    Viswanath B; Kim S; Lee K
    Int J Nanomedicine; 2016; 11():2491-504. PubMed ID: 27330292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?
    Herr R; Brummer T
    Mol Cell Oncol; 2015; 2(4):e1002709. PubMed ID: 27308494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on the Management of Colorectal Cancer in Older Adults.
    O'Donnell CDJ; Hubbard J; Jin Z
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contributions of molecular biology to the management of colorectal cancer].
    Grancher A; Cuissy S; Sefrioui D; Di Fiore F
    Rev Prat; 2024 Apr; 74(4):355-358. PubMed ID: 38814021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to "Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments": [Annals of Oncology 34 (2023) 543-552].
    Ros J; Matito J; Villacampa G; Comas R; Garcia A; Martini G; Baraibar I; Saoudi N; Salvà F; Martin Á; Antista M; Toledo R; Martinelli E; Pietrantonio F; Boccaccino A; Cremolini C; Dienstmann R; Tabernero J; Vivancos A; Elez E
    Ann Oncol; 2024 Aug; ():. PubMed ID: 39138097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.